Achim Schneeberger

3.1k total citations
62 papers, 2.4k citations indexed

About

Achim Schneeberger is a scholar working on Immunology, Molecular Biology and Physiology. According to data from OpenAlex, Achim Schneeberger has authored 62 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Immunology, 16 papers in Molecular Biology and 15 papers in Physiology. Recurrent topics in Achim Schneeberger's work include Immunotherapy and Immune Responses (19 papers), Alzheimer's disease research and treatments (15 papers) and Parkinson's Disease Mechanisms and Treatments (8 papers). Achim Schneeberger is often cited by papers focused on Immunotherapy and Immune Responses (19 papers), Alzheimer's disease research and treatments (15 papers) and Parkinson's Disease Mechanisms and Treatments (8 papers). Achim Schneeberger collaborates with scholars based in Austria, Germany and United States. Achim Schneeberger's co-authors include Markus Mandler, Frank Mattner, Jean‐Luc Coll, Dominique Leprince, C. Lagrou, C. de Taisne, D. Stéhelin, Anne Gégonne, Georg Stingl and Wolfgang Schmidt and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and The Journal of Experimental Medicine.

In The Last Decade

Achim Schneeberger

60 papers receiving 2.3k citations

Peers

Achim Schneeberger
Yvonne Richaud‐Patín Mexico
Tanya Lehky United States
Hiroshi Kuroda Japan
Manuel Deprez Belgium
Norbert Goebels Germany
Padmavathy Vanguri United States
Eileen McMahon United States
Norm Allaire United States
Hiromitsu Kimura Japan
Lawrence C. Kenyon United States
Yvonne Richaud‐Patín Mexico
Achim Schneeberger
Citations per year, relative to Achim Schneeberger Achim Schneeberger (= 1×) peers Yvonne Richaud‐Patín

Countries citing papers authored by Achim Schneeberger

Since Specialization
Citations

This map shows the geographic impact of Achim Schneeberger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Achim Schneeberger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Achim Schneeberger more than expected).

Fields of papers citing papers by Achim Schneeberger

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Achim Schneeberger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Achim Schneeberger. The network helps show where Achim Schneeberger may publish in the future.

Co-authorship network of co-authors of Achim Schneeberger

This figure shows the co-authorship network connecting the top 25 collaborators of Achim Schneeberger. A scholar is included among the top collaborators of Achim Schneeberger based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Achim Schneeberger. Achim Schneeberger is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Abraham, Carmela R., et al.. (2024). AD04 – modifying Alzheimer’s Disease by modulation of neuroinflammation. Alzheimer s & Dementia. 20(S8).
3.
Golombek, Sonia, Thomas Hoffmann, Ludmilla Hann, et al.. (2023). Improved tropoelastin synthesis in the skin by codon optimization and nucleotide modification of tropoelastin-encoding synthetic mRNA. Molecular Therapy — Nucleic Acids. 33. 642–654. 6 indexed citations
4.
Enke, Marcel, et al.. (2023). 3D screen printing technology enables fabrication of oral drug dosage forms with freely tailorable release profiles. International Journal of Pharmaceutics. 642. 123101–123101. 8 indexed citations
5.
Fischer, Dagmar, et al.. (2020). 3D screen printing – An innovative technology for large-scale manufacturing of pharmaceutical dosage forms. International Journal of Pharmaceutics. 592. 120096–120096. 23 indexed citations
6.
Volc, Dieter, Werner Poewe, Alexandra Kutzelnigg, et al.. (2020). Safety and immunogenicity of the α-synuclein active immunotherapeutic PD01A in patients with Parkinson's disease: a randomised, single-blinded, phase 1 trial. The Lancet Neurology. 19(7). 591–600. 105 indexed citations
7.
Hochmann, Sarah, Radmila Santic, Frieder Koszik, et al.. (2018). Evaluation of modified Interferon alpha mRNA constructs for the treatment of non-melanoma skin cancer. Scientific Reports. 8(1). 12954–12954. 12 indexed citations
8.
Schneeberger, Achim, Suzanne Hendrix, Markus Mandler, et al.. (2015). RESULTS FROM A PHASE II STUDY TO ASSESS THE CLINICAL AND IMMUNOLOGICAL ACTIVITY OF AFFITOPE® AD02 IN PATIENTS WITH EARLY ALZHEIMER’S DISEASE. The Journal of Prevention of Alzheimer s Disease. 2(2). 1–12. 32 indexed citations
9.
Mandler, Markus, Radmila Santic, P. Gruber, et al.. (2015). Tailoring the Antibody Response to Aggregated Aß Using Novel Alzheimer-Vaccines. PLoS ONE. 10(1). e0115237–e0115237. 26 indexed citations
10.
Attems, Johannes, Lauren Walker, Radmila Santic, et al.. (2014). Pyroglutamylated Amyloid-beta correlates with Hyperphosphorylated Tau and Severity of Alzheimer's Disease. Journal of Neuropathology & Experimental Neurology. 73(6). 587–587. 1 indexed citations
11.
Mandler, Markus, Lauren Walker, Radmila Santic, et al.. (2014). Pyroglutamylated amyloid-β is associated with hyperphosphorylated tau and severity of Alzheimer’s disease. Acta Neuropathologica. 128(1). 67–79. 50 indexed citations
12.
Greinix, Hildegard, Robert Knobler, Nina Worel, et al.. (2006). The effect of intensified extracorporeal photochemotherapy on long-term survival in patients with severe acute graft-versus-host disease.. PubMed. 91(3). 405–8. 161 indexed citations
13.
Leitner, Gerda, Frieder Koszik, Christoph Buchta, et al.. (2006). Apheresis products of the Amicus™ and the AS.TEC 204® cell separators are comparable with regard to dendritic cells derived from the mononuclear cell collection. Vox Sanguinis. 92(1). 37–41. 2 indexed citations
14.
Kopp, Tamara, Cassian Sitaru, Achim Schneeberger, et al.. (2006). IgA pemphigus – Occurrence of anti‐Desmocollin 1 and anti‐Desmoglein 1 antibody reactivity in an individual patient. JDDG Journal der Deutschen Dermatologischen Gesellschaft. 4(12). 1045–1050. 14 indexed citations
15.
Valencak, Julia, Elisabeth Heere‐Ress, Tatjana Traub‐Weidinger, et al.. (2005). Somatostatin receptor scintigraphy with 111In-DOTA-lanreotide and 111In-DOTA-Tyr3-octreotide in patients with stage IV melanoma: in-vitro and in-vivo results. Melanoma Research. 15(6). 523–529. 10 indexed citations
16.
Schneeberger, Achim, Christine Wagner, Anja Zemann, et al.. (2004). CpG Motifs Are Efficient Adjuvants for DNA Cancer Vaccines. Journal of Investigative Dermatology. 123(2). 371–379. 50 indexed citations
17.
Schneeberger, Achim, Petra Lührs, Peter Steinlein, et al.. (2003). Granulocyte-Macrophage Colony-Stimulating Factor-Based Melanoma Cell Vaccines Immunize Syngeneic and Allogeneic Recipients via Host Dendritic Cells. The Journal of Immunology. 171(10). 5180–5187. 8 indexed citations
18.
Wagner, Stephan N., Christine Wagner, Petra Lührs, et al.. (2000). Intracutaneous Genetic Immunization with Autologous Melanoma-Associated Antigen Pmel17/gp100 Induces T Cell-Mediated Tumor Protection In Vivo. Journal of Investigative Dermatology. 115(6). 1082–1087. 16 indexed citations
19.
20.
Stingl, Georg, E.‐B. Bröcker, Roland Mertelsmann, et al.. (1997). Phase I study to the immunotherapy of metastatic malignant melanoma by a cancer vaccine consisting of autologous cancer cells transfected with the human IL-2 gene. Journal of Molecular Medicine. 75(4). 297–299. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yvonne Richaud‐Patín Breakdown of academic impact, for papers by Tanya Lehky Breakdown of academic impact, for papers by Hiroshi Kuroda Breakdown of academic impact, for papers by Manuel Deprez Breakdown of academic impact, for papers by Norbert Goebels Breakdown of academic impact, for papers by Padmavathy Vanguri Breakdown of academic impact, for papers by Eileen McMahon Breakdown of academic impact, for papers by Norm Allaire Breakdown of academic impact, for papers by Hiromitsu Kimura Breakdown of academic impact, for papers by Lawrence C. Kenyon
Rankless by CCL
2026